Reversal learning and associative memory impairments in a BACHD rat model for huntington disease

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Abada, Yah Se K ^a,b   Nguyen, Huu Phuc ^c   Ellenbroek, Bart ^d   Schreiber, Rudy ^e  

^a EVOTEC AG   (Germany)

^b UNIVERSITY OF BREMEN   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^e UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSOCIATIVE MEMORY; BACHD RAT; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEAR; FLINCH-JUMP TEST; HUNTINGTON CHOREA; LEARNING; LONGITUDINAL STUDY; MALE; MAZE TEST; MEMORY DISORDER; MENTAL PERFORMANCE; NEUROLOGIC EXAMINATION; NONHUMAN; PAIN; PHENOTYPE; RAT; RAT MODEL; SENSITIVITY ANALYSIS; TRANSGENIC RAT;

ANIMALS; ASSOCIATION LEARNING; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; FEAR; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MAZE LEARNING; MEMORY DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; REACTION TIME; REVERSAL LEARNING;

EID: 84891456588     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071633     Document Type: Article

References (60)

1. Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is unstable on Huntington's disease chromosomes. Cell 72: 971-983.
2. Huntington G (1872) "On Chorea". The Medical and Surgical Reporter: A weekly Journal, (Philadelphia: S. Butler), vo. 26, no 15, 317-321.
3. Myers RH, Vonsattel JP, Stevens TJ, Cupples LA, Richardson EP, et al. (1988) Clinical and neuropathologic assessment of severity in Huntington's disease. Neurology. 38(3): 341-7.
4. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, et al. (1985) Neuropathological classification of Huntington's disease J Neuropathol Exp Neurol. 44(6): 559-77.
5. Douaud G, Gaura V, Ribeiro MJ, Lethimonnier F, Maroy R, et al. (2006) Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study. Neuroimage. 32(4): 1562-75.
6. Jones L, Hughes A (2011) Pathogenic mechanisms in Huntington's disease. Int Rev Neurobiol. 98: 373-418.
7. Pidgeon C, Rickards H (2013) The pathophysiology and pharmacological treatment of Huntington disease. Behav Neurol. 26(4): 245-53. doi: 10.3233/BEN-2012-120267.
8. Jackson GR, Salecker I, Dong X, Yao X, Arnheim N, et al. (1998) Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron. 21(3): 633-42.
9. Yang SH, Cheng PH, Banta H, Piotrowska-Nitsche K, Yang JJ, et al. (2008) Towards a transgenic model of Huntington's disease in a non-human primate. Nature. 453(7197): 921-4. Epub 2008 May 18.
10. Crook ZR, Housman D (2011) Huntington's disease: can mice lead the way to treatment? Neuron. 69(3): 423-35.
11. Vlamings R, Zeef DH, Janssen ML, Oosterloo M, Schaper F, et al. (2012) Lessons learned from the transgenic Huntington's disease rats. Neural Plast. 2012: 682712. Epub 2012 Jul 18.
12. Mullard A (2012) Sting of Alzheimer's failures offset by upcoming prevention trials. [Review]. Nat Rev Drug Discov. 11(9): 657-60. doi: 10.1038/nrd3842.
13. Lawrence AD, Barbara JS, John RH, Anne ER, Klaus WL, et al. (1996) Executive and mnemonic functions in early Huntington's disease. Brain 119: 1633-1645.
14. Lawrence AD, John RH, Anne ER, Ann K, Charles C, et al. (1998) Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain 121: 1329-1341.
15. Lawrence AD, Sahakian BJ, Rogers RD, Hodge JR, Robbins TW (1999) Discrimination, reversal, and shift learning in Huntington's disease: mechanisms of impaired response selection. Neuropsychologia. 37(12): 1359-74.
16. Hahn-Barma V, Deweer B, Dürr A, Dodé C, Feingold J, et al. (1998) Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers. J Neurol Neurosurg Psychiatry. 64(2): 172-7.
17. von Hörsten S, Schmitt I, Nguyen HP, Holzmann C, Schmidt T, et al. (2003) Transgenic rat model of Huntington's disease. Hum Mol Genet. 12(6): 617-24.
18. Fielding SA, Brooks SP, Klein A, Bayram-Weston Z, Jones L, et al. (2012) Profiles of motor and cognitive impairment in the transgenic rat model of Huntington's disease. Brain Res Bull. 88(2-3): 223-36.
19. Cao C, Temel Y, Blokland A, Ozen H, Steinbusch HW, et al. (2006) Progressive deterioration of reaction time performance and choreiform symptoms in a new Huntington's disease transgenic ratmodel. Behav Brain Res. 170(2): 257-61.
20. Kántor O, Temel Y, Holzmann C, Raber K, Nguyen HP, et al. (2006) Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington's disease transgenic rats. Neurobiol Dis. 22(3): 538-47.
21. Nguyen HP, Kobbe P, Rahne H, Wörpel T, Jäger B, et al. (2006) Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease. Hum Mol Genet. 15(21): 3177-94. Epub 2006 Sep 19.
22. Zeef DH, van Goethem NP, Vlamings R, Schaper F, Jahanshahi A, et al. (2012) Memory deficits in the transgenic rat model of Huntington's disease. Behav Brain Res. 227(1): 194-8.
23. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, et al. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 87(3): 493-506.
24. Lione LA, Carter RJ, Hunt MJ, Bates GP, Morton AJ, et al. (1999) Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation. J Neurosci. 19(23): 10428-37.
25. Yu-Taeger L, Petrasch-Parwez E, Osmand AP, Redensek A, Metzger S, et al. (2012) A Novel BACHD Transgenic Rat Exhibits Characteristic Neuropathological Features of Huntington Disease. J Neurosci. 32(44): 15426-15438.
26. Gray M, Shirasaki DI, Cepeda C, André VM, Wilburn B, et al. (2008) Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci. 28(24): 6182-95.
27. Abada YS, Nguyen HP, Schreiber R, Ellenbroek B (2013) Assessment of Motor, sensory motor gating and Recognition memory in a novel full-length rat model for Huntington disease. doi: 10.1371/journal.pone.0068584.
28. Fendt M, Fanselow MS (1999) The neuroanatomical and neurochemical basis of conditioned fear. [Review]. Neurosci Biobehav Rev. 23(5): 743-60.
29. Knight DC, Cheng DT, Smith CN, Stein EA, Helmstetter FJ, et al. (2004) Neural substrates mediating human delay and trace fear conditioning. J Neurosci. 24(1): 218-28.
30. Farr SA, Flood JF, Scherrer JF, Kaiser FE, Taylor GT, et al. (1995) Effect of ovarian steroids on footshock avoidance learning and retention in female mice. Physiol Behav. 58(4): 715-23.
31. Pearson R, Lewis MB (2005) Fear recognition across the menstrual cycle. Horm Behav. 47(3): 267-71. Epub 2005 Jan 16.
32. Tolman EC, Ritchie BF, Kalish D (1946) Studies in spatial learning; place learning versus response learning. J Exp Psychol. 36: 221-9.
33. Abada YS, Schreiber R, Ellenbroek B (2013) Motor, emotional and cognitive deficits in adult BACHD mice: A model for Huntington's disease. Behav Brain Res. 238: 243-51. doi: 10.1016/j.bbr.2012.10.039. Epub 2012 Oct 30.
34. Blum S, Runyan JD, Dash PK (2006) Inhibition of prefrontal protein synthesis following recall does not disrupt memory for trace fear conditioning. BMC Neurosci. 7: 67.
35. Lehner M, Wisłowska-Stanek A, Maciejak P, Szyndler J, Sobolewska A, et al. (2010) The relationship between pain sensitivity and conditioned fear response in rats. Acta Neurobiol Exp (Wars). 70(1): 56-66.
36. Blizard DA, Weinheimer VK, Klein LC, Petrill SA, Cohen R, et al. (2006) 'Return to home cage' as a reward for maze learning in young and old genetically heterogeneous mice. Comp Med. 56(3): 196-201.
37. Brooks SP, Betteridge H, Trueman RC, Jones L, Dunnett SB (2006) Selective extra-dimensional set shifting deficit in a knock-in mouse model of Huntington's disease. Brain Res Bull. 69(4): 452-7. Epub 2006 Mar 10.
38. Brooks SP, Janghra N, Higgs GV, Bayram-Weston Z, Heuer A, et al. (2012) Selective cognitive impairment in the YAC128 Huntington's disease mouse. Brain Res Bull. 88(2-3): 121-9. Epub 2011 May 20.
39. Fink KD, Rossignol J, Crane AT, Davis KK, Bavar AM, et al. (2012) Early cognitive dysfunction in the HD 51 CAG transgenic rat model of Huntington's disease. Behav Neurosci. 126(3): 479-87. doi: 10.1037/a0028028.
40. Van Raamsdonk JM, Pearson J, Slow EJ, Hossain SM, Leavitt BR, et al. (2005) Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease. J Neurosci. 25(16): 4169-80.
41. Kirch RD, Meyer PT, Geisler S, Braun F, Gehrig S, et al. (2012) Early deficits in declarative and procedural memory dependent behavioral function in a transgenic rat model of Huntington's disease. Behav Brain Res. 239C: 15-26. doi: 10.1016/j.bbr.2012.10.048.
42. Packard MG, McGaugh JL (1996) Inactivation of hippocampus or caudate nucleus with lidocaine differentially affects expression of place and response learning. Neurobiol Learn Mem. 65(1): 65-72.
43. Packard MG (1999) Glutamate infused posttraining into the hippocampus or caudate-putamen differentially strengthens place and response learning. Proc Natl Acad Sci U S A. 96(22): 12881-6.
44. Ainge JA, Langston RF (2012) Ontogeny of neural circuits underlying spatial memory in the rat. Front Neural Circuits. 6: 8. doi: 10.3389/fncir.2012.00008. Epub 2012 Mar 1.
45. Restle F (1957) Discrimination of cues in mazes: a resolution of the place-vs.- response question. [Review]. Psychol Rev. 64(4): 217-28.
46. Pych JC, Chang Q, Colon-Rivera C, Haag R, Gold PE (2005) Acetylcholine release in the hippocampus and striatum during place and response training. Learn Mem. 12(6): 564-72.
47. Ciamei A, Morton AJ (2009) Progressive imbalance in the interaction between spatial and procedural memory systems in the R6/2 mouse model of Huntington's disease. Neurobiol Learn Mem. 92(3): 417-28.
48. Josiassen RC, Curry LM, Mancall EL (1983) Development of neuropsychological deficits in Huntington's disease. Arch Neurol. 40(13): 791-6.
49. Rogers RD, Andrews TC, Grasby PM, Brooks DJ, Robbins TW (2000) Contrasting cortical and subcortical activations produced by attentional-set shifting and reversal learning in humans. J Cogn Neurosci. 12(1): 142-62.
50. Baldi E, Lorenzini CA, Bucherelli C (2004) Footshock intensity and generalization in contextual and auditory-cued fear conditioning in the rat. Neurobiol Learn Mem. 81(3): 162-6.
51. Rescorla RA (1972) "Configural" conditioning in discrete-trial bar pressing. J Comp Physiol Psychol. 79(2): 307-17.
52. Phillips RG, LeDoux JE (1992) Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci. 106(2): 274-85.
53. Bolivar VJ, Manley K, Messer A (2003) Exploratory activity and fear conditioning abnormalities develop early in R6/2 Huntington's disease transgenic mice. Behav Neurosci. 117(6): 1233-42.
54. Walker AG, Ummel JR, Rebec GV (2011) Reduced expression of conditioned fear in the R6/2 mouse model of Huntington's disease is related to abnormal activity in prelimbic cortex. Neurobiol Dis. 43(2): 379-87. doi: 10.1016/j.nbd.2011.04.009. Epub 2011 Apr 16.
55. Hickey MA, Kosmalska A, Enayati J, Cohen R, Zeitlin S, et al. (2008) Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice. Neuroscience. 157(1): 280-95. doi:10.1016/j.neuroscience.2008.08.041.
56. Faure A, Höhn S, Von Hörsten S, Delatour B, Raber K, et al. (2011) Altered emotional and motivational processing in the transgenic rat model for Huntington's disease. Neurobiol Learn Mem. 95(1): 92-101. doi: 10.1016/j.nlm.2010.11.010. Epub 2010 Nov 25.
57. LeDoux JE (2000) Emotion circuits in the brain. [Review]. Annu Rev Neurosci. 23: 155-84.
58. Gilmartin MR, Helmstetter FJ (2010) Trace and contextual fear conditioning require neural activity and NMDA receptor-dependent transmission in the medial prefrontal cortex. Learn Mem. 17(6): 289-96. doi: 10.1101/lm.1597410.
59. Gilmartin MR, Kwapis JL, Helmstetter FJ (2012) Trace and contextual fear conditioning are impaired following unilateral microinjection of muscimol in the ventral hippocampus or amygdala, but not the medial prefrontal cortex. Neurobiol Learn Mem. 97(4): 452-64. doi: 10.1016/j.nlm.2012.03.009. Epub 2012 Mar 26.
60. Ramaswamy S, Kordower JH (2012) Gene therapy for Huntington's disease. [Review]. Neurobiol Dis. 48(2): 243-54. doi: 10.1016/j.nbd.2011.12.030. Epub 2011 Dec 24.